NEW YORK (GenomeWeb) – Australian diagnostics manufacturer Genetic Signatures announced today that it has received CE marking for a PCR-based kit to detect extended spectrum beta-lactamase (ESBL) and carbapenemase-producing organisms (CPOs).

The firm's EasyScreen ESBL & CPO Kit detects strains of antibiotic-resistant pathogens, often referred to as "superbugs," in less than three hours with minimal hands-on time. It detects a total of 16 beta-lactam and carbapenem-resistant pathogen targets.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Aug
20
Sponsored by
Canon BioMedical

This webinar will provide an overview of recent advances in single-cell RNA sequencing from the perspectives of three research organizations.